FGF23 and diabetic kidney disease: Notably, these bone metabolism markers varied in their timing of changes, with PHOS showing significant differences as early as DKD III group, while FGF23 levels only differed significantly in DKD V group, suggesting that disturbances in bone metabolism play a significant role in the pathological progression of DKD (Table 5).